KKR and Hologic team up to create medical tech platform focused on lung cancer diagnostics
Private-equity firm KKR & Co. Inc. KKR, +7.73%, Hologic Inc. HOLX, +1.04% are teaming up to create a new platform aimed at accelerating innovation in medical technology with an initial focus on lun...
Hologic: Navigating The Covid Cliff
Today, we take a deeper look at diagnostic and medical device concern, Hologic, Inc., whose stock has made a nice run here in November. The company is seeing impressive growth from some of its core...
S&P 500 Gains and Losses Today: Hologic Announces Strong Results, Stock Buyback
U.S. equities rallied Friday to post solid gains, with the S&P 500 adding 1.6% and the Nasdaq soaring 2%. The market powered ahead as bond yields pulled back from their jump Thursday when Fed Chair...
Hologic CEO on Q4 earnings beat, $4 billion cash on balance sheet
Steve MacMillan, Hologic CFO, joins 'Squawk on the Street' to discuss key tailwinds Hologic is seeing, strategic use cases for the company's cash, and playbooks for weight-loss drugs.
Midday Movers: Hologic and Meta Platforms Gain, Illumina Sinks
U.S. equities gained at midday after yesterday's selloff snapped long winning streaks for the S&P 500 and Nasdaq. Bond yields were lower after jumping yesterday when Fed Chair Jerome Powell suggest...
Hologic, Inc. (HOLX) Q4 2023 Earnings Call Transcript
Hologic, Inc. (NASDAQ:HOLX ) Q4 2023 Earnings Call Transcript November 9, 2023 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, Presiden...
Hologic (HOLX) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Hologic (HOLX) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics co...
Hologic fourth-quarter sales beat estimates
Hologic on Thursday reported fourth-quarter sales that beat Wall Street estimates on strong demand in its breast health segment, sending the medtech firm's shares up 2.7% in extended trading.
Unveiling Hologic (HOLX) Q4 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Hologic (HOLX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the...
Hologic (HOLX) Q4 Earnings Might Rise on 7.7% Breast Health Growth
Strength in Breast Health and growing Panther instrument installed base will likely benefit Hologic's (HOLX) Q4 performance.
Here's Why Hologic (HOLX) Fell More Than Broader Market
In the most recent trading session, Hologic (HOLX) closed at $67.56, indicating a -0.37% shift from the previous trading day.
Hologic (HOLX) Ascends But Remains Behind Market: Some Facts to Note
In the latest trading session, Hologic (HOLX) closed at $69.22, marking a +0.35% move from the previous day.
Hologic (HOLX) to Elevate OB-GYN Training With New Partnerships
Hologic's (HOLX) collaboration with AAGL and Inovus Medical is likely to optimize OB-GYN training for minimally invasive surgeries.
Hologic (HOLX) Rises Yet Lags Behind Market: Some Facts Worth Knowing
The latest trading day saw Hologic (HOLX) settling at $70.25, representing a +0.59% change from its previous close.
Hologic (HOLX) to Boost Breast Imaging Modality With New Pact
Hologic's (HOLX) collaboration with Bayer will enable physicians everywhere to include CEM in their breast cancer diagnosis workflows.
Related Companies